Cargando…

三级淋巴结构在非小细胞肺癌预后及免疫治疗中的研究进展

Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, Ying, XIONG, Lei, CAI, Ruoxue, CHEN, Yue, YE, Jinjun, SHEN, Bo, ZHOU, Guoren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558765/
https://www.ncbi.nlm.nih.gov/pubmed/37752541
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.23